LAB REPORT

Customer Care Number

Accuprobe 9599593622
9599593625
Diagnostics
Accurecy Mattern.. Certificete No.: MC-2097
NABLAccredted Pathology Laboratoy
Barcode No 10583109 Lab No 00012112161031
Palicnt Name Ms.POONAM Reg Date 16/Dec/2021 06:19AM
Age/ Sex 37 YRS/Female Sample Coll. Date 16/Dec/2021 06:18 AM
Refered By DR. KK LAB Sample Rec.Date 16/Dec/2021 06:21 AM
Client Code/Name APO80276 KK LAB
Ref. Lab/Hosp Report Date 16/Dec/2021 09:20AM
Panel Address BATHINDA

Test Name With Methodology Result Unit Biological Ref.lnterval

Thyroid Profile-I [T3,T4,TSH]
T3 (Trilodothyronine) 167 ng/dl 60-181
Arrm. Iectro
(he nli Luminescent Tmmuno Assay

T4 (Thyroxine) 7.90 ug/dl 4.5-12.6

Ser um, Eeectro C hemi Lominecent imuno
Assay

TSH(Ultrasensitive) 1.08 ulUiml 0.13-6.33

SrnlevtroChemi I.uninescent lwmunr Assay
Comments:
Our
reteronce range applies the central 95th interval
(2.5th-97.5th quantie)
according to the CLSUIFCC guidelines EPZ*AJC
a vanauon in serum Ish in healhy subjects is well documented. TSH level is reaching peak levels between 2-4 am and at a minimum beween b-10 pm. ine vdiauo o ueo
%,
the day has infuence on the value of TSH.

e . and 1ou
may represent Subdinical
compensated hypothyroidism show considerable
or

H
or
physiological&seasonal variation, suggest dinical correlatuon or repear tesuig wu E sample.
IOvpls may b0
iransienty altered because
of
non-thyroid ilness, like severe infection, renal disease, liver disease, heart disease, severe bums, trauma, SUrgery etc. SH values.
OnOn rew orgoo
esu neans undaraclive thyroid gland caused
an
by faiure of the gland (hypothyroidism).
gland that prevents it from producing TSH.
A low result can
TSH indicate an overactive thyroid gland (hyperthyroidism) oamage P r " 7
or o

Resistance to thyrold hormone (RTH) and central

hyperthyroidism (TSH-oma) are rare conditions associated with elevaled TSH, T4 and T3 levels.
Below mentioned are the guldelines for age reference
Age
ranges for T3,T4 and TSH results:
Total T3 (ng/di) Total T4 (Hg/dll) TSH (PIUim
-b0days 3-2 B8
5.04- 18 07-15.0
80-275 5.41-1.0
*Chonuns 0.72-11.0
yeas
5.67-116.0 0.73-6. 35
248 5.95-114.7
O.70-.5
yeas 93-231 5.99-13.8
12- 20 years g1
218
.o0.64
20 years
5.91-13 6.50
TSH Level tn pregnancy
H.50-12 6.33
First Trimester 0.10-2.5 plU/m
Second Irimester
0.20- 3.0 piu/m
hird Trinester
.30-3.0 pluim

The tests marked with an are not accredited by NABL.

*** End Of Report ***

Hashan
Dr Jay Prakash Singh (MD, Path)
Dr Prashant Goyal (DCP)
tConsultant Pathologist)
(Chief Pathologist)
Page 1 of
TIF

Accuprobe Healthcare &Diagnostics Pvt. Ltd.

ISO
UASL
1.2018
Reference Lab/Corporate Office : 614/7, Jhilmil Industrial PAB
Area, G.T. Road, Delhi -

110095,Tel:- 011-67774666/67774633, 67774632

info@accuprobe.in www.accuprobe.in
 LAB REPORT
Customer Care Number
9599593622
AcCuprobe
9599593625
Diagnostics
AccureyMetters

Barcode No
10583109
Certificate No.; MC-2097
NABL Accredted

Lab No
Patholbgy Laboratory

00012112161031
NUANANA
Ms.POONAM Reg Date 16/Dec/2021 06:19AM
Patient Name
37 YRS/Female Sample Coll. Date 16/Dec/2021
AgeSex DR. K KLAB Sample Rec.Date 16/Dec/2021 06:21 AM
Refered By
APO80276 KK LAB
Client Code/Name
Report Date 17/Dec/2021 05:02PM
Ref Lab/Hosp
Panel Address BATHINDA

ANA (Anti Nuclear Antibodies) IFA with Titers

ANTI NUCLAER ANTIBoDY (BY IMMUNO FLOURSCENCE)

Dilution (D) 1:80

Intensity On If Intensity (++)
Pattern NUCLEOLAR
Expected Titer 1:320
Follow-Up Testing Clinical correlation and/or repeat testing after 6-12 weeks and lor confirmation by
ANA profile
Interpretation: Positive

Pattern Type of Antibody/ Disease Associations

Antigenic determinants
dsDNA, Nucleosomes SLE, Drug Induced LE, other Rheumatic
HomogenousChromatin), Histones
'

diseases
Sm, U1-RNP, SSA(Ro), SLE, Sjögren's Syndrome, Mixed Connective
Speckled SSB(La), Scl-70 Tissue Disease, Evolving Rheumatic
Disease, Scleroderma
SSA SSA Sjogren's Syndrome, SLE, Neonatal Lupus
Fibrillarin, Pm-Scl, RNA
Nucleolar. Polymerase, NOR90, Th- Scleroderma, Scleroderma/Myositis
To
Centromere CENPA, B, C CREST form öf Scleroderma
Nuclear Dots Sp-100, MND, NSp- Primary Biliary Cirrhosis
PCNA PCNA SLE
Nuclear Nuclear Lamins Lupoid Hepatitis, SLE, RA
Membrane

o
Dr Prashant Goyal (DCP)
Dr Jay Prakash Singh (MD, Path)
(Consultant Pathologist)
(Chief Pathologist)

UASL
IS
e i e e Dt I td